Abstract
The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Conn JW. Interpretation of the glucose tolerance test. The necessity of a standard preparatory diet. Am J Med Sci. 1940;199:555–64. https://doi.org/10.1097/00000441-194004000-00014.
Jagannathan R, Neves JS, Dorcely B, et al. The Oral Glucose Tolerance Test: 100 years later. Diabetes Metab Syndr Obes. 2020;13:3787–805. https://doi.org/10.2147/DMSO.S246062.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57. https://doi.org/10.2337/diab.28.12.1039.
Makkar BM, Vasanth Kumar CH, Saboo B, Agarwal S, On behalf of RSSDI 2022 Consensus Group. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2022. Int J Diabetes Dev Ctries. 2022;42(Suppl 1):1–143. https://doi.org/10.1007/s13410-022-01129-5.
Abdul-Ghani MA, Abdul-Ghani T, Stern MPK, et al. Two-step approach for the prediction of future type 2 diabetes risk. Diabetes Care. 2011;34:2108–12. https://doi.org/10.2337/dc10-2201.
Alyass A, Almgren P, Akerlund M, et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58:87–97. https://doi.org/10.1007/s00125-014-3390-x.
Priya M, Anjana RM, Chiwanga FS, Gokulakrishnan K, Deepa M, Mohan V. 1-hour venous plasma glucose and incident prediabetes and diabetes in Asian Indians. Diabetes Technol Ther. 2013;15:497–502. https://doi.org/10.1089/dia.2013.0025.
Pramodkumar T, Priya M, Jebarani S, Anjana R, Mohan V, Pradeepa R. Metabolic profile of normal glucose-tolerant subjects with elevated 1-h plasma glucose values. Indian J Endocrinol Metab. 2016;20:612–8. https://doi.org/10.4103/2230-8210.19053.
Sai Prasanna N, Amutha A, Pramodkumar TA, et al. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects. J Diabetes Complications. 2017;31:1592–6. https://doi.org/10.1016/j.jdiacomp.2017.07.017.
Kumpatla S, Parveen R, Stanson S, Viswanathan V. Elevated one hour with normal fasting and 2 h plasma glucose helps to identify those at risk for development of type 2 diabetes-11 years observational study from south India. Diabetes Metab Syndr. 2019;13:2733–7. https://doi.org/10.1016/j.dsx.2019.06.029.
Bergman M, Buysschaert M, Ceriello A, et al. Current diagnostic criteria identify risk for type 2 diabetes too late. Lancet Diabetes Endocrinol. 2023;11:224–6. https://doi.org/10.1016/S2213-8587(23)00039-6.
Bergman M, Manco M, Satman I, et al. International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Res Clin Pract. 2024; Published : March 06, 2024. https://doi.org/10.1016/j.diabres.2024.111589.
DeFronzo RA, Abdul-Ghani MA. Preservation of β-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011;96:2354–66. https://doi.org/10.1210/jc.2011-0246.
Staimez LR, Weber MB, Ranjani H, et al. Evidence of reduced β-cell function in Asian Indians with mild dysglycemia. Diabetes Care. 2013;36:2772–8. https://doi.org/10.2337/dc12-2290.
Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759–63.
Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians-the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab. 2007;9:337–43. https://doi.org/10.1111/j.1463-1326.2006.00612.x.
Mohan V, Anbalagan VP. Expanding role of the madras diabetes research foundation - indian diabetes risk score in clinical practice. Indian J Endocrinol Metab. 2013;17:31–6. https://doi.org/10.4103/2230-8210.107825.
Mohan V, Goldhaber-Fiebert JD, Radha V, Gokulakrishnan K. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res. 2011;133:294–9.
Bala S, Pandve H, Kamala K, Dhanalakshmi A, Sarikonda H. Performance of Indian diabetic risk score as a screening tool of diabetes among women of industrial urban area. J Family Med Prim Care. 2019;8:3569–73. https://doi.org/10.4103/jfmpc.jfmpc_799_19.
Singh MM, Mangla V, Pangtey R, Garg S. Risk assessment of diabetes using the Indian Diabetes Risk Score: a study on young medical students from Northern India. Indian J Endocrinol Metab. 2019;23:86–90. https://doi.org/10.4103/ijem.IJEM_623_18.
Rooney MR, Fang M, Ogurtsova K, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46:1388–94. https://doi.org/10.2337/dc22-2376.
Mohan V, Unnikrishnan R, Anjana RM. Comment on Rooney et al. Global prevalence of prediabetes. Diabetes Care 2023;46:1388-1394. Diabetes Care. 2023;46:e220. https://doi.org/10.2337/dc23-1606.
Anjana RM, Unnikrishnan R, Deepa M, ICMR-INDIAB Collaborative Study Group, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11:474–89. https://doi.org/10.1016/S2213-8587(23)00119-5.
Sattar N, Gill JM. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol. 2015;3:1004–16. https://doi.org/10.1016/S2213-8587(15)00326-5.
Anjana RM, Shanthi Rani CS, Deepa M, et al. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care. 2015;38:1441–8. https://doi.org/10.2337/dc14-2814.
Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–9. https://doi.org/10.1016/S2213-8587(18)30051-2.
Anjana RM, Baskar V, Nair ATN, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study. BMJ Open Diabetes Res Care. 2020;8:e001506. https://doi.org/10.1136/bmjdrc-2020-001506.
Das S, Samal KC, Baliarsinha AK, Tripathy BB. Lean (underweight) NIDDM - peculiarities and differences in metabolic and hormonal status - a pilot study. J Assoc Physicians India. 1995;43:339–42.
Mohan V, Vijayaprabha R, Rema M, et al. Clinical profile of lean NIDDM in South India. Diabetes Res Clin Pract. 1997;2:101–8. https://doi.org/10.1016/s0168-8227(97)00088-0.
Unnikrishnan R, Anjana RM, Mohan V. Diabetes in South Asians: is the phenotype different? Diabetes. 2014;63:53–5. https://doi.org/10.2337/db13-1592.
Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci. 2013;1281:51. https://doi.org/10.1111/j.1749-6632.2012.06838.x.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent to participate
Not relevant as it is a review article.
Conflict of interest
The authors declare no competing interests.
Research involving human participants and/or animals
Not relevant.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sahay, R., Mohan, V., Agarwal, S. et al. RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes. Int J Diabetes Dev Ctries 44, 216–219 (2024). https://doi.org/10.1007/s13410-024-01345-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-024-01345-1